Senseonics Holdings (SENS) Current Deferred Revenue (2015 - 2018)
Senseonics Holdings' (SENS) quarterly Current Deferred Revenue came in at $628000.0 in Q4 2018, up 6877.78% quarter-over-quarter from $9000.0 in Q1 2016.
Powered by 
Analysis
Senseonics Holdings (SENS) Current Deferred Revenue (2015 - 2018) Analysis & Trends
Senseonics Holdings (SENS) has reported Current Deferred Revenue for 3 consecutive years, with $628000.0 the latest figure, recorded in Q4 2018.
- On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $628000.0 in Q4 2018; TTM through Dec 2018 was $628000.0, a N/A change from a year earlier, with the FY2018 full-year figure at $628000.0, changed N/A from the prior year.
- Current Deferred Revenue was $628000.0 for Q4 2018 at Senseonics Holdings, up from $9000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $628000.0 in Q4 2018 and troughed at $7000.0 in Q4 2015.
- A 3-year average of $214666.7 and a median of $9000.0 in 2016 frame the typical range for Current Deferred Revenue.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Senseonics Holdings | 509.09 Mn | 268.48 Mn | 8.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 628,000.00 |
| Mar 31, 2016 | 9,000.00 |
| Dec 31, 2015 | 7,000.00 |